McCawber

So it seems there was a good business in Regenersis after all. ROCE OF 68% Earnings growth of 24% Good cash flow Great balance sheet Low tax rate Shares on the move and still looks cheap to me.

Have a look at the share price on RGS-LON. The price and volume look like stake-building. That might be good news because this company appears to be horribly run - is there an opportunity here? It should be a relatively attractive business and it certainly looks cheap but the're seem to be some some very good reasons for its dog status over the last three…